BACKGROUND The most common technique for treating benign and early malignant rectal lesions is transanal endoscopic microsurgery(TEM).Local excision is an acceptable technique for high-risk and elderly patients,but th...BACKGROUND The most common technique for treating benign and early malignant rectal lesions is transanal endoscopic microsurgery(TEM).Local excision is an acceptable technique for high-risk and elderly patients,but there are hardly any data regarding young patients.AIM To describe TEM outcomes in patients under 50 years of age.METHODS We collected demographic,clinical,and pathological data from all patients under the age of 50 years who underwent the TEM procedure at Hasharon Rabin Medical Center from January 2005 to December 2018.RESULTS During the study period,a total of 26 patients under the age of 50 years underwent TEM procedures.Their mean age was 43.3 years.Eleven(42.0%)were male.The mean operative time was 67 min,and the mean tumor size was 2.39 cm,with a mean anal verge distance of 8.50 cm.No major intraoperative or postoperative complications were recorded.The median length of stay was 2 d.Seven(26.9%)lesions were adenomas with low-grade dysplasia,four(15.4%)were high-grade dysplasia adenomas,two were T1 carcinomas(7.8%),and three were T2 carcinomas(11.5%).No residual disease was found following endoscopic polypectomy in two patients(7.8%),but four(15.4%)had other pathologies.Surgical margins were negative in all cases.Local recurrence was detected in one patient 33 mo following surgery.CONCLUSION Among young adult patients,TEM for benign rectal lesions has excellent outcomes.It may also offer a balance between the efficacy of complete oncologic resection and postoperative quality of life in the treatment of rectal cancer.In some cases,it may be considered an alternative to radical surgery.展开更多
BACKGROUND Trans-anal endoscopic microsurgery(TEM)enables a good visualization of the surgical field and is considered the method of choice for excision of adenomas and early T1 rectal cancer.The rectum and retro-rect...BACKGROUND Trans-anal endoscopic microsurgery(TEM)enables a good visualization of the surgical field and is considered the method of choice for excision of adenomas and early T1 rectal cancer.The rectum and retro-rectal space might be the origin of uncommon neoplasms,benign and aggressive,certain require radical trans-abdominal surgery,while others can be treated by a less aggressive approach.In this study we report outcomes in patients undergoing TEM for rare and non-adenomatous rectal and retro-rectal lesions over a period of 11 years.METHODS Between January 2008 to December 2019 a retrospective analysis was completed for all patients who underwent TEM for non-adenomatous rectal lesion or retro-rectal mass in our institution.Patients were discharged once diet was well tolerated and no complications were identified.They were evaluated at 3 wk post operatively,then at 3-mo intervals for the first 2 years and every 6 mo depending on the nature of the final pathology.Clinical examination and rectoscopy were performed during each of the follow-up visits.RESULTS Out of 198 patients who underwent TEM during the study period,18 had non-adenomatous rectal or retro-rectal lesions.Mean age was 47 years.The mean size of the lesions was 2.9 mm,with a mean distance from the anal margin of 7.9 cm.Mean surgical time was 97.8 min.There were no intra-operative neither late post-operative complications.Mean length of stay was 2.5 d.Mean patient follow-up duration was 42 mo.CONCLUSION TEM allows for reduced morbidity given its minimally invasive nature.Surgeons should be familiar with the technique but careful patient selection should be considered.It can be used safely for uncommon rectal and selected retro-rectal lesions without compromising outcomes.We believe that it should be reasonably considered as one of the surgical methods when treating rare lesions.展开更多
Purpose: Despite many scientific advances, Regenerative Medicine is still in the preclinical stages in many areas. In this article, we intend to discuss the role of microsurgery in the bench-to-bedside transition of s...Purpose: Despite many scientific advances, Regenerative Medicine is still in the preclinical stages in many areas. In this article, we intend to discuss the role of microsurgery in the bench-to-bedside transition of such primary findings. Method: By searching the papers related to the history of Regenerative Medicine (RM) and the news of Tissue Engineering (TE) in orthopedics in Pubmed, Scopus, and Google Scholar databases, we accessed a complete archive of various topics related to this field. Result: We first assessed the history and achievements of regenerative medicine, then we realized the importance of translational medical sciences and the role of animal models in this incipient phenomenon. Finally, after mastering the capabilities of microsurgery and the useful contribution of this technique to the advancement of clinical applications of regenerative medicine in various branches such as skin, skeletal system, nerves, and blood vessels, we decided to express the gist of our studies through this article. Conclusion: Considering the widespread use of small animals in regenerative medicine projects and the inevitable role of microsurgery in performing the best intervention on these animal models, the significant progress of regenerative medicine clinical application requires special attention to microsurgery in associated research.展开更多
背景甲基化CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)在基因转录调控中发挥重要作用,研究表明MeCP2可能是胶质瘤治疗的一个新靶点,但其在胶质瘤中的表达与患者预后的关系尚不清楚。目的探讨MeCP2在胶质瘤中的表达与患者手术后...背景甲基化CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)在基因转录调控中发挥重要作用,研究表明MeCP2可能是胶质瘤治疗的一个新靶点,但其在胶质瘤中的表达与患者预后的关系尚不清楚。目的探讨MeCP2在胶质瘤中的表达与患者手术后临床预后的关系。方法选择2016年1月—2018年10月在贵阳市第二人民医院神经外科手术治疗的临床病理资料完整的96例胶质瘤患者,应用免疫组织化学方法检测肿瘤组织和正常脑组织中MeCP2的表达,随访患者生存情况。采用Kaplan-Meier法进行生存分析;采用Cox单因素和多因素风险回归模型分析MeCP2表达水平及相关临床病理因素与患者生存预后的关系。结果96例患者获得随访,其中男51例,女45例,年龄7~79岁,平均年龄(44.9±18.3)岁。免疫组化结果显示胶质瘤组织中MeCP2阳性表达率高于正常脑组织(75.0%vs 30.0%,P<0.05)。MeCP2表达的阳性率在WHOⅠ~Ⅳ级胶质瘤组织中分别为20.0%、66.7%、75.0%、90.6%(1/5、18/27、24/32、29/32),在高级别胶质瘤(WHOⅢ、Ⅳ级)中的阳性表达率高于低级别胶质瘤(WHOⅠ、Ⅱ级),差异有统计学意义(P<0.05)。70例出现肿瘤复发,59例死亡,中位无进展生存期(progression-free survival,PFS)和总生存期(overall survival,OS)分别为(10.7±1.7)个月和(24.1±2.9)个月。Kaplan-Meier生存分析显示,胶质瘤患者中MeCP2高表达组的中位PFS和OS显著低于低表达组[PFS:(15.6±1.8)个月vs(28.0±2.6)个月,P=0.026;OS:(16.1±2.0)个月vs(28.3±5.8)个月,P=0.022]。Cox回归分析显示,MeCP2高表达(HR:1.705,95%CI:1.019~2.854)、肿瘤病变多发(HR:2.727,95%CI:1.453~5.120)、单纯采用手术治疗(HR:1.704,95%CI:1.015~2.861)、高病理级别(WHOⅢ、Ⅳ级)(HR:3.294,95%CI:2.317~4.683)是胶质瘤患者预后不良的独立危险因素。结论MeCP2在胶质瘤手术患者中表达水平上调,且高表达水平与胶质瘤患者术后不良预后相关。展开更多
目的探讨显微外科手术治疗重症高血压性脑桥出血[出血量>5 mL、格拉斯哥昏迷评分(Glasgow Coma Scale,GCS)3~4分]的效果。方法回顾性分析2016年1月—2021年5月临沂市中医医院脑血管病中心内科保守治疗的重症高血压性脑桥出血患者[出...目的探讨显微外科手术治疗重症高血压性脑桥出血[出血量>5 mL、格拉斯哥昏迷评分(Glasgow Coma Scale,GCS)3~4分]的效果。方法回顾性分析2016年1月—2021年5月临沂市中医医院脑血管病中心内科保守治疗的重症高血压性脑桥出血患者[出血量(8.35±1.64)mL,GCS评分3~4分]共19例为内科治疗组;同期行CT定位血肿腔穿刺的18例重症高血压性脑桥出血患者[出血量(9.09±1.43)mL,GCS评分3~4分]为穿刺治疗组;同期显微外科手术治疗的21例重症高血压性脑桥出血患者[出血量(8.79±1.35)mL、GCS评分3~4分]为手术治疗组。按格拉斯哥预后评分(Glasgow Outcome Scale,GOS)评估预后,比较3组患者1、3个月存活患者例数。结果内科治疗组患者1个月时按GOS评分重残和植物状态生存10例,死亡9例;3个月时按GOS评分重残和植物状态生存8例,死亡2例。穿刺治疗组患者术后1月时按GOS评分重残和植物状态生存12例,死亡6例;术后3月时按GOS评分重残和植物状态生存11例,死亡1例。手术治疗组患者术中无死亡病例,术后患者自主呼吸均逐渐恢复,术后2周未出现多器官功能衰竭及电解质紊乱,2周时无死亡病例,术后1个月时按GOS评分:重残和植物状态生存20例,死亡1例;术后3个月时按GOS评分:重残和植物状态生存18例,死亡2例。1、3个月时比较内科治疗组、穿刺治疗组和手术治疗组存活患者,差异有统计学意义(χ^(2)=9.496、8.294,P<0.05)。结论对重症脑桥出血患者早期行显微外科手术治疗是简便、安全、有效的治疗方法,配合规范化神经外科重症管理,与穿刺治疗和内科治疗相比可以明显降低患者病死率。展开更多
文摘BACKGROUND The most common technique for treating benign and early malignant rectal lesions is transanal endoscopic microsurgery(TEM).Local excision is an acceptable technique for high-risk and elderly patients,but there are hardly any data regarding young patients.AIM To describe TEM outcomes in patients under 50 years of age.METHODS We collected demographic,clinical,and pathological data from all patients under the age of 50 years who underwent the TEM procedure at Hasharon Rabin Medical Center from January 2005 to December 2018.RESULTS During the study period,a total of 26 patients under the age of 50 years underwent TEM procedures.Their mean age was 43.3 years.Eleven(42.0%)were male.The mean operative time was 67 min,and the mean tumor size was 2.39 cm,with a mean anal verge distance of 8.50 cm.No major intraoperative or postoperative complications were recorded.The median length of stay was 2 d.Seven(26.9%)lesions were adenomas with low-grade dysplasia,four(15.4%)were high-grade dysplasia adenomas,two were T1 carcinomas(7.8%),and three were T2 carcinomas(11.5%).No residual disease was found following endoscopic polypectomy in two patients(7.8%),but four(15.4%)had other pathologies.Surgical margins were negative in all cases.Local recurrence was detected in one patient 33 mo following surgery.CONCLUSION Among young adult patients,TEM for benign rectal lesions has excellent outcomes.It may also offer a balance between the efficacy of complete oncologic resection and postoperative quality of life in the treatment of rectal cancer.In some cases,it may be considered an alternative to radical surgery.
文摘BACKGROUND Trans-anal endoscopic microsurgery(TEM)enables a good visualization of the surgical field and is considered the method of choice for excision of adenomas and early T1 rectal cancer.The rectum and retro-rectal space might be the origin of uncommon neoplasms,benign and aggressive,certain require radical trans-abdominal surgery,while others can be treated by a less aggressive approach.In this study we report outcomes in patients undergoing TEM for rare and non-adenomatous rectal and retro-rectal lesions over a period of 11 years.METHODS Between January 2008 to December 2019 a retrospective analysis was completed for all patients who underwent TEM for non-adenomatous rectal lesion or retro-rectal mass in our institution.Patients were discharged once diet was well tolerated and no complications were identified.They were evaluated at 3 wk post operatively,then at 3-mo intervals for the first 2 years and every 6 mo depending on the nature of the final pathology.Clinical examination and rectoscopy were performed during each of the follow-up visits.RESULTS Out of 198 patients who underwent TEM during the study period,18 had non-adenomatous rectal or retro-rectal lesions.Mean age was 47 years.The mean size of the lesions was 2.9 mm,with a mean distance from the anal margin of 7.9 cm.Mean surgical time was 97.8 min.There were no intra-operative neither late post-operative complications.Mean length of stay was 2.5 d.Mean patient follow-up duration was 42 mo.CONCLUSION TEM allows for reduced morbidity given its minimally invasive nature.Surgeons should be familiar with the technique but careful patient selection should be considered.It can be used safely for uncommon rectal and selected retro-rectal lesions without compromising outcomes.We believe that it should be reasonably considered as one of the surgical methods when treating rare lesions.
文摘Purpose: Despite many scientific advances, Regenerative Medicine is still in the preclinical stages in many areas. In this article, we intend to discuss the role of microsurgery in the bench-to-bedside transition of such primary findings. Method: By searching the papers related to the history of Regenerative Medicine (RM) and the news of Tissue Engineering (TE) in orthopedics in Pubmed, Scopus, and Google Scholar databases, we accessed a complete archive of various topics related to this field. Result: We first assessed the history and achievements of regenerative medicine, then we realized the importance of translational medical sciences and the role of animal models in this incipient phenomenon. Finally, after mastering the capabilities of microsurgery and the useful contribution of this technique to the advancement of clinical applications of regenerative medicine in various branches such as skin, skeletal system, nerves, and blood vessels, we decided to express the gist of our studies through this article. Conclusion: Considering the widespread use of small animals in regenerative medicine projects and the inevitable role of microsurgery in performing the best intervention on these animal models, the significant progress of regenerative medicine clinical application requires special attention to microsurgery in associated research.
